Page last updated: 2024-12-05

promecarb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Promecarb is a carbamate insecticide that was first synthesized in the 1960s. It is a broad-spectrum insecticide that is effective against a wide range of pests, including aphids, caterpillars, and beetles. Promecarb is known for its quick knockdown effect and its relatively short persistence in the environment. It works by inhibiting the enzyme acetylcholinesterase, which is essential for nerve transmission. Promecarb is no longer widely used due to concerns about its toxicity to non-target organisms, including birds, fish, and beneficial insects. However, it continues to be studied for its potential applications in pest control, especially in developing countries. Research is ongoing to investigate its use in integrated pest management programs and its possible role as a biopesticide.'

promecarb: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID17516
CHEMBL ID1076537
CHEBI ID82096
SCHEMBL ID121314
MeSH IDM0053431

Synonyms (85)

Synonym
LS-14104
phenol, 3-methyl-5-(1-methylethyl)-, methylcarbamate
carbamic acid, methyl-, m-cym-5-yl ester
ep 316
carbamult
sch 34615
sn 34615
promecarb
carbamic acid, m-cym-5-yl ester
sn-316
carbamic acid, 3-methyl-5-isopropylphenyl ester
m-cym-5-yl methylcarbamate
schering 34615
promecarbe
3-methyl-5-isopropylphenyl methylcarbamate
2631-37-0
wln: 1y1&r c1 eovm1
nsc35378
3-methyl-5-isopropylphenyl n-methylcarbamate
nsc-35378
oms 716
3-isopropyl-5-methylphenyl n-methylcarbamate
uc 9880
ent 27,300-a
minacide
morton ep-316
3-isopropyl-5-methylphenyl methylcarbamate
promecarb [bsi:iso]
3-methyl-5-isopropylphenyl-n-methylcarbamate
3-methyl-5-(1-methylethyl)phenol methylcarbamate
t-32
3-methyl-5-isopropyl n-methylcarbamate
hsdb 1554
5-isopropyl-m-tolyl methylcarbamate
nor-am
ent 27300-a
3-methyl-5-(1-methylethyl)phenolmethylcarbamate
einecs 220-113-0
carbamic acid, n-methyl-, 3-methyl-5-isopropylphenyl ester
3-methyl-5-(1-methylethyl)phenyl methylcarbamate
(3-methyl-5-isopropylphenyl)-n-methylcarbamat [german]
phenol, 3-methyl-5-(1-methylethyl)-, methyl carbamate
rcra waste no. p201
carbamic acid, methyl-, 3-methyl-5-(1-methylethyl)phenyl ester
ai3-27300
ent 27300
methylcarbamic acid m-cym-5-yl ester
brn 2111695
5-methyl-m-cumenyl methylcarbamate
caswell no. 271c
union carbide uc-9880
epa pesticide chemical code 271400
nsc 35378
promecarbe [iso-french]
NCGC00163793-01
(3-methyl-5-propan-2-ylphenyl) n-methylcarbamate
chebi:82096 ,
CHEMBL1076537
C18956
(3-methyl-5-isopropylphenyl)-n-methylcarbamat
1qrp20775s ,
unii-1qrp20775s
dtxsid4037617 ,
tox21_301424
dtxcid2017617
NCGC00255587-01
cas-2631-37-0
FT-0603615
SCHEMBL121314
sn-34615
promecarb [hsdb]
promecarb [iso]
ep-316
promecarb [mi]
3-methyl-5-(1-methylethyl)phenyl n-methylcarbamate
sch-34615
DTAPQAJKAFRNJB-UHFFFAOYSA-N
phenol,3-methyl-5-(1-methylethyl)-,1-(n-methylcarbamate)
promecarb, pestanal(r), analytical standard
4111-89-1
promecarb 100 microg/ml in cyclohexane
J-016375
Q7249684
CAA63137
phenol, 3-methyl-5-(1-methylethyl)-, 1-(n-methylcarbamate)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkylbenzeneA monocyclic arene that is benzene substituted with one or more alkyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency1.55880.002541.796015,848.9004AID1347395; AID1347397; AID1347398; AID1347399
RAR-related orphan receptor gammaMus musculus (house mouse)Potency58.57370.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency57.71100.000714.592883.7951AID1259392
AR proteinHomo sapiens (human)Potency43.27710.000221.22318,912.5098AID1259247
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency54.48270.001022.650876.6163AID1224839
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency54.94100.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency38.17960.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency12.93180.000817.505159.3239AID1159527; AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency38.57080.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency30.89560.000229.305416,493.5996AID743069; AID743078
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's2 (20.00)18.2507
2000's2 (20.00)29.6817
2010's2 (20.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.80 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]